Back |
home / stock / nvcr / nvcr message board
Subject | By | Source | When |
---|---|---|---|
You got that Absolutely right norisknorewards.. | KIPK | investorshub | 01/10/2023 4:06:41 PM |
Easiest short he said | Penny chatter | investorshub | 01/10/2023 2:34:43 PM |
We shall see | Penny chatter | investorshub | 01/10/2023 2:26:02 PM |
FDA Cleared CHEMO as well just incase... And | KIPK | investorshub | 01/10/2023 2:03:59 PM |
Could be this am conference today? Novocure plans to | Penny chatter | investorshub | 01/10/2023 1:29:41 PM |
We are pleased with the positive readout of | Penny chatter | investorshub | 01/10/2023 1:27:30 PM |
I penny pumper writing a narrative that's about | Penny chatter | investorshub | 01/10/2023 1:25:46 PM |
$NVCR microwave device hype will not last and | KIPK | investorshub | 01/10/2023 12:45:20 PM |
LOL -- I tried to short this a | Pedro2004 | investorshub | 01/06/2023 3:09:18 PM |
$NVCR: You said it....... ust hit $185 in PreMarket | makinezmoney | investorshub | 01/05/2023 12:26:34 PM |
Get ready for a ride! | Mister Happy | investorshub | 01/03/2023 3:57:16 AM |
How many shares of $NVCR will be sold | HappyLibrarian | investorshub | 10/24/2022 7:02:28 PM |
News, Short Squeeze, Breakout and More Instantly...
NovoCure Limited Company Name:
NVCR Stock Symbol:
NASDAQ Market:
2024-05-03 01:00:11 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q1 2024 Earnings Call May 02, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q1 2024 Earnings Call Transcript
Use of proceeds to fund working capital needs stemming from Novocure’s anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure’s convertible notes Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 milli...